Never before has the issue of breast cancer been so front and center in the media limelight. Between the public unfolding of personal opinions on the efficacy of breast cancer screening methods and Angelina Jolie's controversial announcement of her prophylactic double mastectomy, there is no denying that when it comes to breast cancer, there is still much work to be done.
We are united in
our shared responsibility to fund research, our shared demand that it adheres to the highest standards, and our shared responsibility to ensure that its benefits are translated to the clinic, for the patients who need it.
But, if the privileged experience of working with this incredible Foundation has taught me anything, it is that the road ahead of us continues to be paved with solutions. The only obstacle in our course is a lack of research funding. At a time when sequestration threatens medical research budgets nationwide, the role of the individual and the private sector could not be more critical. To eradicate this disease that continues to affect far too many women, men, and families across the world, we need a mass commitment.
With a portfolio of the world's greatest collective brain trust of more than 200 committed researchers globally, we know that we can find the answers in science - if only we dedicate ourselves to this mission. Thank you to all of the individuals, groups, companies and organizations whose dedication and support enable us to continue to fund the world's most promising research. Together, we can realize a world without breast cancer.
Myra J. Biblowit
BCRF President, Myra Biblowit, honored by Women in Development with the
2012 Woman of Achievement Award